Menu

J. Morelle MD, PhD

Articles

Monoclonal gammopathy of renal significance

BJH - volume 11, issue 8, december 2020

M.C. Vekemans MD, J. Morelle MD, PhD

SUMMARY

Monoclonal gammopathy of renal significance (MGRS) represents a heterogeneous group of diseases in which a monoclonal immunoglobulin, secreted by a plasma or B-cell clone with no evidence of malignancy, causes renal damage. As MGRS patients have a high risk of developing permanent kidney damage, adequate diagnosis and treatment are required to preserve kidney function. In this review, we address the definition, mechanisms and classification of MGRS, and discuss how patients with suspected MGRS should be evaluated and managed.

(BELG J HEMATOL 2020;11(8):376-80)

Read more

P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience

BJH - volume 11, issue Abstract Book BHS, february 2020

F. Andreozzi , I. Dufour , A. Sogorb , S. Chabert , G. Verstraete MD, J. Raedemaeker , L. Bamps , S. Bailly MD, F. Jamar , F. Lecouvet , A. Camboni MD, PhD, J-P. Defour PhD, dr. A-C. Pouleur , J. Morelle MD, PhD, M.C. Vekemans MD

Read more

P46 About a case of allogenic hematopoietic stem cell transplant-associated thrombotic microangiopathy

BJH - 2018, issue Abstract Book BHS, february 2018

Y. Berners , A. Capes , F. Dall’Armellina , L. Maindiaux , J. Morelle MD, PhD, K. Claes BM, PhD, C. Lambert MD, PhD, X. Poiré MD, PhD, M.C. Vekemans MD

Read more
Top